The World Health Organization defines pharmacovigilance, often known as drug safety, as "the science and activities concerned with the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems." The ultimate purpose of pharmacovigilance is to ensure that medicines are used safely, with the dangers associated with the medical product being minimized and the benefits being maximized. It is critical in ensuring that doctors and patients have adequate information to make an informed decision when selecting a medicine for treatment. Mechanisms for evaluating and monitoring the safety of therapeutics in clinical use are critical for preventing or reducing harm to patients and consequently improving public health. In the next ten years, pharmacovigilance programs will briefly outline the probable ramifications of such tendencies on the evolution of science. In this global pitch, pharmacovigilance is confronting numerous problems in developing improved health care systems.
- Adverse Drug Reactions
- Drug Safety Monitoring
Submit your abstract Today
Title : Engineered nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Liver biopsy handling of metabolic-associated fatty liver disease (mafld): The children's hospital of eastern ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada